Defense Health Program Department of Defense Orthotics and Prosthetics Outcomes Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21)
The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense OPORP to support supports research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).
FY21 OPORP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.
The vision of the OPORP is to ensure the highest possible quality of life for our injured Service members, Veterans, and beneficiaries through the advancement of knowledge in orthotics- and prosthetics-related practice. The OPORP supports research on outcomes-based best practices through analysis of prosthetic and/or orthotic device options that are currently available, and not on the development of new devices or the improvement of an existing technology. Projects involving spinal orthoses, pediatric populations, or analysis of short-term use devices will not be considered for the FY21 OPORP.
Applications submitted to the FY21 OPORP must address one or more of the following focus areas:
- Orthoses or Prostheses Form: Optimize patient outcomes through the analysis and characterization of variables related to the form of currently available clinical options such as device size, shape, material, and/or configurations.
- Orthoses or Prostheses Fit: Optimize patient outcomes related to the human-device interface through the analysis of variables in currently available clinical options that facilitate fit-related metrics such as comfort, limb health, and/or usability.
- Orthoses or Prostheses Control: Optimize patient outcomes through the analysis of variables related to currently available device mechanisms such as device control, sensors, and passive or active response.
- Orthoses or Prostheses Function: Optimize patient outcomes by analyzing device-inclusive care protocols and interventions to inform best practices such as evaluation and prescription, timing of interventions, community functioning, and multidisciplinary approaches to clinical care in order to understand short- and long-term outcomes with respect to activities of daily living and other real-world activities.
https://cdmrp.army.mil/funding/oporp
Clinical Research Award – Letter of Intent due July 15, 2021
Independent investigators at all academic levels (or equivalent)
Supports research that evaluates orthoses and/or prostheses using patient-centric outcomes relevant to Service Members, Veterans, and other individuals with limb loss and/or limb impairment.
Supported research is intended to generate clinically useful evidence with potential to enhance and optimize patient outcomes, and inform clinical or policy decisions.
Multidisciplinary collaboration among academia, industry, patient advocacy, the military Services, the Department of Veterans Affairs (VA), and/or other federal government agencies is highly encouraged.
Applications submitted to the FY21 OPORP CRA must address at least one of the FY21 OPORP Focus Areas.
Preclinical studies using animals are not allowed.
Clinical trials are not allowed.
The FY21 OPORP CRA offers two funding levels:
Funding Level 1:
Maximum funding of $350,000 for total costs (direct costs plus indirect costs)
Maximum period of performance is 2 years
Funding Level 2:
Maximum funding of $2,000,000 for total costs (direct costs plus indirect costs)
Maximum period of performance is 4 years
Clinical Trial Award – Letter of Intent due July 15, 2021
Independent investigators at all academic levels (or equivalent)
Supports implementation of clinical trials with the potential to have a significant impact on improving the health and well-being of Service Members and military beneficiaries, Veterans, and other individuals with limb loss and/or limb impairment.
Supports clinical trials that evaluate orthoses and/or prostheses using patient-centric outcomes for the purpose of generating clinically useful evidence to enhance and optimize patient outcomes.
Multidisciplinary collaboration among academia, industry, patient advocacy, the military Services, VA, and/or other federal government agencies is highly encouraged.
Applications submitted to the FY21 OPORP CTA must address at least one of the FY21 OPORP Focus Areas.
Preclinical studies using animals are not allowed.
The FY21 OPORP CTA offers two funding levels:
Funding Level 1:
Maximum funding of $350,000 for total costs (direct costs plus indirect costs)
Maximum period of performance is 3 years
Funding Level 2:
Maximum funding of $4,000,000 for total costs (direct costs plus indirect costs)
Maximum period of performance is 4 years
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the OPORP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
help@eBrap.org